MENLO PARK, CA, Biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, has raised $7.0 million in its first round of financing. Read More
DALLAS, TX, Shirtmaker and haberdasher, today announced a significant milestone in the company's two-year history with the closing of $1.2 million in Series A funding. Read More